Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants

World J Gastroenterol. 2006 Aug 21;12(31):5033-6. doi: 10.3748/wjg.v12.i31.5033.

Abstract

Aim: To study the role of an insertion/deletion polymorphism in the pepsinogen C (PGC) gene, an effective marker for terminal differentiation of the stomach mucosa, in the susceptibility to the development of gastric lesions.

Methods: The study was performed with 99 samples of known gastric lesions and 127 samples without evidence of neoplastic disease. PCR was employed and the 6 polymorphic alleles were amplified: Allele 1 (510 bp), Allele 2 (480 bp), Allele 3/4 (450/460 bp), Allele 5 (400 bp) and Allele 6 (310 bp).

Results: Our results revealed that Allele 6 carriers seemed to have protection against the development of any gastric lesion (OR = 0.34; P<0.001), non-dysplastic lesions associated with gastric adenocarcinoma such as atrophy or intestinal metaplasia (OR = 0.28; P<0.001) or invasive GC (OR = 0.39; P = 0.004).

Conclusion: Our study reveals that the Allele 6 carrier status has a protective role in the development of gastric lesions, probably due to its association with higher expression of PGC. Moreover, the frequency of Allele 6 carriers in the control group is far higher than that obtained in Asian populations, which might represent a genetic gap between Caucasian and Asian populations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Biomarkers, Tumor*
  • Cross-Sectional Studies
  • DNA / metabolism
  • Genetic Variation*
  • Humans
  • Intestinal Mucosa / pathology*
  • Odds Ratio
  • Pepsinogen C / genetics*
  • Polymorphism, Genetic*
  • Risk
  • Stomach Neoplasms / ethnology
  • Stomach Neoplasms / genetics*
  • White People

Substances

  • Biomarkers, Tumor
  • Pepsinogen C
  • DNA